+
Site Tour

MitraClip - AVVS 1 year 1 minute Mitral - Video

The most significant moments of the past year | Mitral focus

LEARN MORE:

AV Valves Summit 2024

Related Videos

Navigating the Anatomy | Tricuspid focus

Case Parade | Tricuspid focus

TriClip - AVVS 1 year 1 minute Tricuspid - Video

Case Transmission | Tricuspid focus

AV Valves Summit 2024 | Opening of Day 2

AV VALVES 2023: Morphology

AV VALVES 2023: TR – Big Gaps

LAAO Summit - Sealing the appendage

PremiClose 2024: Pediatric cardiologist view

ESOC 2023: AF patient LAA case

AV VALVES 2023: Staged, Concomitant

TRENDING TOPICS

AV Valves Summit 2024 | Opening of Day 2

AV Valves Summit 2024 | Opening of Day 2

F. Maisano, M. Metra, M. Sitges, R. S. Von Bardeleben

AV Valves Summit 2024 | Closing of Day 1

AV Valves Summit 2024 | Closing of Day 1

F. Maisano, M. Metra, M. Sitges, R. S. Von Bardeleben

Case Parade | Tricuspid focus

Case Parade | Tricuspid focus

M. Sitges, R. Estevez, V. Ninios, E. L. Heng, X. Freixa, W. Wojakowski, C. Besler

CONNEXT


TV
RELATED RESOURCES

LAAO Summit 2022: Live case: Denmark

Clot or not K. Piayda

Grill the expert: LAAO beyond bleeding I. Eitel

LAAO Summit 2023: LAAO device

CONNEXT


HUB
RELATED RESOURCES

TRILUMINATE Pivotal - 2-year update EuroPCR 25

2-year outcomes from the TRILUMINATE Pivotal trial

Amplatzer™ Septal Occluder (ASO) technical brochure

Prognosis of TR after MitraClip for MR

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline